Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Coronary Artery Disease: HELP
Graham Mazereeuw
Based on 6 articles published since 2008
||||
Expertise Level
The expertise of Graham Mazereeuw ranks in the Graphical view (beta)
Uncounted papers?
Work Locations
Details
Most likely:    University of Toronto   Contact    
2017
  • Department of Medicine, University of Toronto, Toronto, Ontario, Canada. · Hurvitz Brain Sciences Program, Sunnybrook Research Institute and Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. · Centre for Addiction and Mental Health, and Departments of Pharmacology/Toxicology and Psychiatry, University of Toronto, Toronto, Ontario, Canada. · Centre for Addiction and Mental Health, Toronto, Ontario, Canada. · Department of Human Health and Nutritional Sciences, University of Guelph, Guelph, Ontario, Canada. · University Health Network at Toronto Rehabilitation Institute, Toronto, Ontario, Canada. · Hurvitz Brain Sciences Program, Sunnybrook Research Institute and Departments of Psychiatry and Pharmacology/Toxicology, University of Toronto, Toronto, Ontario, Canada. Electronic address: · Pubmed 27742581
2016
  • From the *Hurvitz Brain Sciences Program, Sunnybrook Research Institute; Departments of †Pharmacology and Toxicology and ‡Psychiatry, University of Toronto; and §University Health Network at Toronto Rehabilitation Institute, Toronto; ∥Department of Human Health and Nutritional Sciences, University of Guelph, Guelph; and ¶Trillium Health Partners, Toronto, Ontario, Canada. · Pubmed 27529771
  • Sunnybrook Research Institute, Toronto, Ontario, Canada; Department of Medicine, University of Toronto, Toronto, Ontario, Canada. · Sunnybrook Research Institute, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. · Department of Human Health and Nutritional Sciences, University of Guelph, Guelph, Ontario, Canada. · Sunnybrook Research Institute, Toronto, Ontario, Canada; University Health Network at Toronto Rehabilitation Institute, Toronto, Ontario, Canada. · Sunnybrook Research Institute, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; University Health Network at Toronto Rehabilitation Institute, Toronto, Ontario, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada. Electronic address: · Pubmed 26697998
2013
  • Sunnybrook Research Institute, Toronto, Ontario, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada; Neural Regeneration Laboratory, Ottawa Institute of Systems Biology, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada; CIHR Training Program in Neurodegenerative Lipidomics, Canada. · Pubmed 23800745
2014
  • Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Room FG08, Toronto, ON M4N 3M5, Canada. · Pubmed 24996486
Probable:    University Health Network of Toronto      
2016
  • From the *Hurvitz Brain Sciences Program, Sunnybrook Research Institute; Departments of †Pharmacology and Toxicology and ‡Psychiatry, University of Toronto; and §University Health Network at Toronto Rehabilitation Institute, Toronto; ∥Department of Human Health and Nutritional Sciences, University of Guelph, Guelph; and ¶Trillium Health Partners, Toronto, Ontario, Canada. · Pubmed 27529771
Probable:    University of Guelph      
2016
  • From the *Hurvitz Brain Sciences Program, Sunnybrook Research Institute; Departments of †Pharmacology and Toxicology and ‡Psychiatry, University of Toronto; and §University Health Network at Toronto Rehabilitation Institute, Toronto; ∥Department of Human Health and Nutritional Sciences, University of Guelph, Guelph; and ¶Trillium Health Partners, Toronto, Ontario, Canada. · Pubmed 27529771
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Graham Mazereeuw in 2008-2019 about Coronary Artery Disease:

  • Oxidative stress predicts depressive symptom changes with omega-3 fatty acid treatment in coronary artery disease patients. 2017
  • Omega-3 Fatty Acids, Depressive Symptoms, and Cognitive Performance in Patients With Coronary Artery Disease: Analyses From a Randomized, Double-Blind, Placebo-Controlled Trial. 2016
  • Omega-3/omega-6 fatty acid ratios in different phospholipid classes and depressive symptoms in coronary artery disease patients. 2016
  • Platelet-activating factors are associated with cognitive deficits in depressed coronary artery disease patients: a hypothesis-generating study. 2014
  • Platelet activating factors in depression and coronary artery disease: a potential biomarker related to inflammatory mechanisms and neurodegeneration. 2013
  • Exercise intervention and inflammatory markers in coronary artery disease: a meta-analysis. 2012
Show List of Full Article Records
Google Searches

Learn more about Graham Mazereeuw using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Toronto
University Health Network of Toronto
University of Guelph
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Toronto
2017
  • Department of Medicine, University of Toronto, Toronto, Ontario, Canada. · Hurvitz Brain Sciences Program, Sunnybrook Research Institute and Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. · Centre for Addiction and Mental Health, and Departments of Pharmacology/Toxicology and Psychiatry, University of Toronto, Toronto, Ontario, Canada. · Centre for Addiction and Mental Health, Toronto, Ontario, Canada. · Department of Human Health and Nutritional Sciences, University of Guelph, Guelph, Ontario, Canada. · University Health Network at Toronto Rehabilitation Institute, Toronto, Ontario, Canada. · Hurvitz Brain Sciences Program, Sunnybrook Research Institute and Departments of Psychiatry and Pharmacology/Toxicology, University of Toronto, Toronto, Ontario, Canada. Electronic address: · Pubmed 27742581
2016
  • From the *Hurvitz Brain Sciences Program, Sunnybrook Research Institute; Departments of †Pharmacology and Toxicology and ‡Psychiatry, University of Toronto; and §University Health Network at Toronto Rehabilitation Institute, Toronto; ∥Department of Human Health and Nutritional Sciences, University of Guelph, Guelph; and ¶Trillium Health Partners, Toronto, Ontario, Canada. · Pubmed 27529771
  • Sunnybrook Research Institute, Toronto, Ontario, Canada; Department of Medicine, University of Toronto, Toronto, Ontario, Canada. · Sunnybrook Research Institute, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. · Department of Human Health and Nutritional Sciences, University of Guelph, Guelph, Ontario, Canada. · Sunnybrook Research Institute, Toronto, Ontario, Canada; University Health Network at Toronto Rehabilitation Institute, Toronto, Ontario, Canada. · Sunnybrook Research Institute, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; University Health Network at Toronto Rehabilitation Institute, Toronto, Ontario, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada. Electronic address: · Pubmed 26697998
2013
  • Sunnybrook Research Institute, Toronto, Ontario, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada; Neural Regeneration Laboratory, Ottawa Institute of Systems Biology, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada; CIHR Training Program in Neurodegenerative Lipidomics, Canada. · Pubmed 23800745
2014
  • Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Room FG08, Toronto, ON M4N 3M5, Canada. · Pubmed 24996486
University Health Network of Toronto
2016
  • From the *Hurvitz Brain Sciences Program, Sunnybrook Research Institute; Departments of †Pharmacology and Toxicology and ‡Psychiatry, University of Toronto; and §University Health Network at Toronto Rehabilitation Institute, Toronto; ∥Department of Human Health and Nutritional Sciences, University of Guelph, Guelph; and ¶Trillium Health Partners, Toronto, Ontario, Canada. · Pubmed 27529771
University of Guelph
2016
  • From the *Hurvitz Brain Sciences Program, Sunnybrook Research Institute; Departments of †Pharmacology and Toxicology and ‡Psychiatry, University of Toronto; and §University Health Network at Toronto Rehabilitation Institute, Toronto; ∥Department of Human Health and Nutritional Sciences, University of Guelph, Guelph; and ¶Trillium Health Partners, Toronto, Ontario, Canada. · Pubmed 27529771
University of Ottawa
2013
  • Sunnybrook Research Institute, Toronto, Ontario, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada; Neural Regeneration Laboratory, Ottawa Institute of Systems Biology, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada; CIHR Training Program in Neurodegenerative Lipidomics, Canada. · Pubmed 23800745
Miscellaneous institutions in Toronto
2012
  • Sunnybrook Research Institute, Toronto, Ontario, Canada. · Pubmed 22520533
Yearly article counts 001201110000
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.